BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

Mutability of DNA polymerase I: Implications for the creation of mutant DNA polymerases [An article from: DNA Repair]

Mutability of DNA polymerase I: Implications for the creation of mutant DNA polymerases [An article from: DNA Repair]
by: E. Loh, L.A. Loeb

Bioportfolio's Price: $8.95
Prices subject to change.


This product in another region: UK | USA



Availability: Available for download now


Click to buy


Editorial Review:

Product Description:
This digital document is a journal article from DNA Repair, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
DNA polymerases of the Family A catalyze the addition of deoxynucleotides to a primer with high efficiency, processivity, and selectivity-properties that are critical to their function both in nature and in the laboratory. These polymerases tolerate many amino acid substitutions, even in regions that are evolutionarily conserved. This tolerance can be exploited to create DNA polymerases with novel properties and altered substrate specificities, using rational design and molecular evolution. These efforts have focused mainly on the Family A DNA polymerises -Taq, E. coli Pol I, and T7 - because they are widely utilized in biotechnology today. The redesign of polymerases often requires knowledge of the function of specific residues in the protein, including those located in six evolutionarily conserved regions. The most well characterized of these are motifs A and B, which regulate the fidelity of replication and the incorporation of nucleotide analogs such as dideoxynucleotides. Regions that remain to be more thoroughly characterized are motif C, which is critical for catalysis, and motifs 1, 2 and 6, all of which bind to DNA primer or template. Several recently identified mutants with abilities to incorporate nucleotides with bulky adducts have mutations that are not located within conserved regions and warrant further study. Analysis of these mutants will help advance our understanding of how DNA polymerases select bases with high fidelity.







Mutability of DNA polymerase I: Implications for the creation of mutant DNA polymerases [An article from: DNA Repair] Mutability of DNA polymerase I: Implications for the creation of mutant DNA polymerases [An article from: DNA Repair]

 


BioPortfolio - Taq Polymerase
Taq Polymerase - BioPortfolio - Indepth. ... BioPortfolio Ltd. offers e-mail and postal lists for Taq Polymerase scientists - we have details of around 168 ...
http://www.bioportfolio.com/indepth/Taq_Polymerase.html...

The Taq Wars Competitive Intelligence on How to Survive
Because many of its enzymes—including Taq polymerase—are thermostable, it thrives in ... The thermostability of Taq polymerase is the critical feature that ...
http://www.bioportfolio.com/cgi-bin/acatalog/The_Taq_Wars_Co...

BioPortfolio - Taq Polymerase research
Recent Publications on Taq Polymerase:. Copper-adenine complex, a compound, with multi-biochemical targets and potential anti-cancer effect. ...
http://www.bioportfolio.com/indepth/Taq_Polymerase/research....

BioPortfolio Taq Polymerase InDepth
View the current Taq Polymerase InDepth page on BioPortfoliocom ... Taq Polymerase Patents. • 7399471 Polypeptides capable of forming antigen binding ...
http://www.bioportfolio.com/indepth/Taq_Polymerase.pdf...

BioInformatics - Life Science Products,Synthetic Oligonucleotides ...
As the engine that fuels the polymerase chain reaction (PCR), one of the most important inventions in molecular biology, Taq polymerase has transformed how ...
http://www.bioportfolio.com/bioreports/BioInformatics.htm...

BioPortfolio - bioline usa
The primer pairs and the universal primer were combined in a master mix containing a Hot Start Taq polymerase (Bioline, USA Inc, Randolph, MA, USA). ...
http://www.bioportfolio.com/search/bioline_usa.html...

BioPortfolio - fermentas life sciences uk
using Taq DNA polymerase (Fermentas Life Sciences Canada, Burlington ON). ... M of each primer, 1.25 U of Taq polymerase (Fermentas, Life Sciences, ...
http://www.bioportfolio.com/search/fermentas_life_sciences_u...

RNA Polymerase Ii - B00070OO1O - Monica H. M Shander
RNA interference (RNAi) has rapidly evolved into a powerful technique to silence .... Taq polymerase has transformed how life science research is conducted. ...
http://www.bioportfolio.com/bookshop/search/RNA+Polymerase+I...

BioPortfolio GENENCO
TAT TTT GAA GGG AGA AAG GCG GAC AG3′MMedical Genenco Florence Italy and 2.5 U of Taq polymeraseApplied BioSystems Roche Molecular Systems ...
http://www.bioportfolio.com/search/GENENCO_.html...

BioPortfolio - life technologies Belgium
U/μL Taq polymerase Platinum (Invitrogen Life Technologies, Merelbeke, Belgium), ... http://www.cdc.gov/Ncidod/EID/vol12no02/05-0847.htm. ...
http://www.bioportfolio.com/search/life_technologies_Belgium...

Recent Searches for Books on Bioportfolio:

| omar w. rosales | margaret trouncer | 013008462X | Black Hair Growth Techniques | Black Hair Growth Techniques | how to start a book publishing company | how to start a book publishing company | 0978727932 | 0978727932 | 1932819576 | 1932819576 | Intro Org Lab Tech Small 2e (Brooks Cole Laboratory Series for Organic Chemistry) (Hardcover) by PAVIA (Author) | Intro Org Lab Tech Small 2e (Brooks Cole Laboratory Series for Organic Chemistry) (Hardcover) by PAVIA (Author) |
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.